Status:
COMPLETED
Targeting Self-regulatory Deficits Through Cognitive Remediation Intervention
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Drug Use Disorders
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
We are proposing a small randomized clinical trial in which 100 substance users will complete the existing Psychotherapy Development Center (PDC) pretreatment assessment battery as well as a novel bat...
Detailed Description
Participants will be 100 individuals (aged 18 to 50) enrolled in outpatient (non- methadone/buprenorphine) treatment for any substance use disorder (other than PCP) at the Substance Abuse Treatment Un...
Eligibility Criteria
Inclusion
- Meet current DSM-5 criteria for an alcohol, stimulant, cannabis, or opioid use disorder.
- Are sufficiently stable for 4 weeks of outpatient treatment.
- Are willing to provide locator information.
- Are fluent in English and have a 4th grader or higher reading level
Exclusion
- Meet DSM-5 criteria for a bipolar or schizophrenic disorder.
- Who have a legal case pending such that incarceration during the 4-week protocol is likely.
- Are physically dependent on alcohol, opioids or benzodiazepines or who report recent PCP use.
- Have a baseline Shipley estimated IQ less than 70
- Have 3 or more head injuries with loss of consciousness for over 30 minutes or lasting effects
- Have a history of chronic illness or neurological disorders (e.g., epilepsy or stroke) that would complicate evaluation of effects of cognitive training
Key Trial Info
Start Date :
January 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 17 2019
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT03373240
Start Date
January 22 2018
End Date
October 17 2019
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Substance Abuse Treatment Center (SATU)
New Haven, Connecticut, United States, 06511